Return to search

Ablation Frontiers Raises Series C

Ablation Frontiers Inc., a Carlsbad, Calif.-based medical device company focused on developing treatments for irregular heart rhythms, has raised $21.8 million in Series C funding.  Novartis Venture Fund led the deal, and was joined by Affinity Ventures, Hexagon Investments and Trellis Health Ventures. Return backers included Versant Ventures, Aberdare Ventures and Pequot Ventures. The company has raised $40.3 million in total VC funding since its 2004 inception. www.ablationfrontiers.com